Mitoxantrone use in breast cancer patients with elevated bilirubin
- 1 December 1989
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 14 (3) , 267-274
- https://doi.org/10.1007/bf01806298
Abstract
A definitive recommendation regarding use of reduced 8 mg/m2 mitoxantrone in patients with severe hyperbilirubinemia and favorable performance status requires further study.Keywords
This publication has 22 references indexed in Scilit:
- Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer.Journal of Clinical Oncology, 1989
- Clinical course of breast cancer patients with liver metastases.Journal of Clinical Oncology, 1987
- Mitoxantrone: A New Anticancer Drug with Significant Clinical ActivityAnnals of Internal Medicine, 1986
- Mitoxantrone: an overview of safety and toxicityInvestigational New Drugs, 1985
- Phase II trial of mitoxantrone in patients with primary liver cancer.1984
- Mitoxantrone metabolism in the isolated perfused rat liverCancer Chemotherapy and Pharmacology, 1984
- FAILURE OF CHEMOTHERAPY TO PROLONG SURVIVAL IN A GROUP OF PATIENTS WITH METASTATIC BREAST CANCERThe Lancet, 1980
- Clinical studies of 5‐fluorouracil + premarin in the treatment of breast cancerMedical and Pediatric Oncology, 1975
- A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesBiometrika, 1965
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958